Abstract
A strategic assessment of the competitive environment is unquestionably one of
the highest priority management responsibilities -- crucial to business
survival, growth and profitability. Timely and factual competitive
intelligence is vital to the success of all business functions, especially
Planning, Marketing, R&D and Manufacturing. In a highly dynamic and fragmented
pharmaceutical market, besieged by intense competition,the rapid pace of
technological innovations, and the uncertainty regarding future government
regulations, the ability to anticipate new competitive product introductions
and marketing strategies is particularly important... and spells the
difference between success and failure.
The Top 10, a unique series of market intelligence studies introduced by
VENTURE PLANNING GROUP in 1987, is designed to provide the pharmaceutical
industry executives with strategically significant competitor information,
analysis, and insight critical to the development intense uncertainty and
implementation of effective marketing and R&D programs.The study' s major
objectives include:
- To establish a comprehensive, factual, annually-updated and costeffective
information base on performance, capabilities, goals and strategies of the
world' s leading pharmaceutical companies.
- To help current suppliers realistically assess their financial, marketing
and technological capabilities vis-a-vis leading competitors.
- To assist potential market entrants in evaluating prospective acquisitions
and joint venture candidates.
- To complement organizations' internal competitor information gathering
efforts by providing strategic analysis, data interpretation and insight.
- To identify the least competitive market niches with significant growth
potential.
Methodology
VENTURE PLANNING GROUP' S DATABASE
VPG' s proprietary data files contain current information on major
pharmaceutical companies, technologies, products and executives worldwide.
These files, developed in the course of over 100 syndicated and numerous
single-client studies, were thoroughly searched to retrieve any information
pertinent to the Top 10 companies' capabilities and strategies.
SECONDARY INFORMATION SOURCES
A comprehensive review of the Top 10 companies' product and financial
literature, business and technical periodicals, and pertinent industry analyst
reports was conducted.
Table of Contents
- I. Executive Summary
- II. Business Organization
- III. Senior Management
- IV. Facilities and Employees
- V. Technological Know-How
- VI. Product Portfolio
- VII. Marketing Tactics
- VIII. Sales and Profit Growth, 2001-2005
- IX. R&D Expenditures and Major Programs
- X. Collaborative Arrangements
- XI. Strategic Direction
|
